Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A comparison of factor VIII infusion methods

M Cox, J Smith, R Miller

    Nursing Times
    |December 6, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    The use of intermediate-purity clotting factor concentrates and HIV disease progression in men with haemophilia.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Factor IX inhibitors and anaphylaxis in haemophilia B.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Factor IX inhibitors and anaphylaxis in hemophilia B.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.

    Journal of thrombosis and haemostasis : JTH·2015

    This case study evaluates two factor VIII infusion methods for haemophilia patients undergoing orthopaedic surgery. The findings offer insights into optimal treatment strategies for managing bleeding disorders during surgical procedures.

    Area of Science:

    • Orthopaedic Surgery
    • Haematology
    • Pharmacology

    Background:

    • Haemophilia A is a genetic bleeding disorder requiring careful management, especially during surgical interventions.
    • Factor VIII concentrate is the standard treatment for haemophilia A, but optimal infusion strategies require further investigation.
    • Orthopaedic operations in haemophilia patients present a high risk of bleeding, necessitating effective prophylaxis and treatment.

    Observation:

    • This study presents a case study of a haemophilia patient undergoing two orthopaedic operations.
    • Two distinct methods of factor VIII infusion were administered and compared for efficacy and safety.
    • The patient's clinical response and laboratory parameters were monitored throughout the treatment period.

    Findings:

    Related Experiment Videos

  • The comparative analysis of factor VIII infusion methods provides data on their effectiveness in preventing and managing bleeding during orthopaedic surgery.
  • Specific findings highlight the advantages or disadvantages of each method in the context of the patient's surgical procedures.
  • The case study demonstrates the practical application of different factor VIII dosing and timing regimens.

    • Implications:

    • The results can inform clinical decision-making regarding the most effective factor VIII infusion protocols for haemophilia patients undergoing orthopaedic surgery.
    • This research contributes to the evidence base for managing complex bleeding disorders in surgical settings.
    • Further studies may be warranted to validate these findings in a larger patient cohort.